What are you searching for?

06.06.2022 | Tracker

Top 50 Pharma Tracker

CREATION Team photo of Marketing Assistant Chawanzi Chintu By Francesca Gan and Chawanzi Chintu

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

May RankApril RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer9,96095641
22Johnson & Johnson1,532666124
33AstraZeneca87329123
45Abbott83255162
54GSK51018738
66Gilead Sciences465644
77Roche39217251
88Novartis38127651
916AbbVie26522914
1013Sanofi25415528
1111Bayer2419815
129Lilly2291767
1315Novo Nordisk22119120
1414Merck & Co20818131
1519Takeda20520015
1610Biogen138570
1712BMS13712510
1820Boehringer Ingelheim1097429
1924Teva988225
2023Regeneron94304
2118Amgen89548
2217Fresenius875715
2332Daiichi Sankyo73386
2431Servier67443
2526UCB655417
2622Otsuka6190
2725Merck KGaA554929
2834Ipsen49359
2929Chugai3411
3033Allergan2630
3128Bausch2553
3227Eisai19101
3335Alexion17111
3439Mylan1610
3530CSL15125
3621Astellas1251
3736Grifols1000
3837Vertex960
3938Menarini610
4041Mitsubishi Tanabe Pharma431
4140Sun110
5050Jiangsu Hengrui000
5050Ono000
5050Endo000
5050Meiji000
5050Yunnan Baiyao000
5050Aurobindo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during April 2022 were Pfizer, Johnson & Johnson, AstraZeneca, Abbott and GSK.

CREATION.co identified a 30% increase in mentions of pharmaceutical companies by HCPs this month compared to last month, increasing from 13,006 to 16,943 posts. Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing opinions following the release of FDA requested Pfizer vaccine documents, as well as news about side effects and the efficacy of AstraZeneca’s vaccine. Abbott also rose one spot in the ranking due to the widespread news of their infant formula recall.

The top shared links by HCPs discussed multiple issues surrounding COVID-19 vaccines:

  1. A news article from the Telegraph about the possible side effects of AstraZeneca’s COVID-19 vaccine.
  2. An ICAN Archive about Pfizer’s vaccine data from the FDA’s FOIA Litigation.
  3. A news article from the Washington Post about the effectiveness of Pfizer’s COVID-19 shot in younger children.

Graph showing HCPs dicussing Pfizer COVID-19 documentsThe prominent driver of conversation in May 2022 came from HCP discussions of the release of the Pfizer documents at the beginning of the month. HCPs celebrated the successful approval of the Pfizer vaccine in children aged 6 months to 5 years. As trial data showed a strong immune response in the children who participated with preliminary data evidencing about 80% efficacy against Omicron.

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In April 2022, CREATION Pinpoint® identified 16,943 healthcare professional (HCP) authored tweets from 5,363 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 May and 31 May 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In May 209 of these posts mentioned Janssen.

The Top 50 Pharma tracker archive

April 2022: HCPs celebrate the success of Lilly’s tirzepatide for obesity and discuss COVID-19 vaccine efficacy

Top 50 Table
Top 50 Insights

March 2022: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Top 50 Table
Top 50 Insights

February 2022: HCPs discuss Healthcare inequity and vaccination of under 5 year olds

Top 50 Table
Top 50 Insights

January 2022: HCPs get political when discussing Regeneron’s COVID-19 treatment

Top 50 Table
Top 50 Insights

December 2021: Omicron variant dominates HCP conversation in December 2021

Top 50 Table
Top 50 Insights

November 2021 : HCPs discuss trial data of Pfizer’s COVID-19 booster vaccine and oral treatment

Top 50 Table
Top 50 Insights

October 2021 : Pfizer most discussed company with booster and children’s COVID-19 jabs

Top 50 Table
Top 50 Insights

July 2021: HCPs discuss “booster shot” to decrease the high spread of the Delta variant

Top 50 Table
Top 50 Insights

June 2021: HCPs discuss effectiveness of COVID-19 vaccines against delta strain.

Top 50 Table
Top 50 Insights

May 2021: HCPs discuss accessibility of COVID-19 treatments globally.

Top 50 Table
Top 50 Insights

April 2021: HCPs reassure the public as they discuss COVID-19 vaccine side effects.

Top 50 Table
Top 50 Insights

March 2021: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Top 50 Table
Top 50 Insights

February 2021: J&J FDA approval of single-dose vaccine stirs HCP conversations

Top 50 Table
Top 50 Insights

January 2021: J&J new vaccine data drives increase in company posts online

Top 50 Table
Top 50 Insights

December 2020: COVID-19 makes up 84% of total conversation

Top 50 Table
Top 50 Insights

November 2020: Vaccine success dwarfs all other conversation.

Top 50 Table
Top 50 Insights

October 2020: Regeneron tops list due to high profile COVID-19 treatment conversation.

Top 50 Table
Top 50 Insights

September 2020: ASTRAZENECA’S VACCINE TRIAL SAFETY DISCUSSED BUT TRANSPARENCY IS CELEBRATED.

Top 50 Table
Top 50 Insights

August 2020: HCPS DISCUSS ASTRAZENECA MORE THAN GILEAD FOR FIRST TIME SINCE PANDEMIC

Top 50 Table
Top 50 Insights

July 2020: COVID-19 CANDIDATES TAKE OVER ALL HCP CONVERSATION

Top 50 Table
Top 50 Insights

June 2020: HCPs respond to COVID-19 treatment options

Top 50 Table
Top 50 Insights

May 2020: HCPs track pharma covid-19 developments online

Top 50 Table
Top 50 Insights

April 2020: HCPS RESPOND TO PHARMA COVID-19 ACTIVITY

Top 50 Table
Top 50 Insights

March 2020: HCPS MENTIONING PHARMA IN RELATION TO COVID-19

Top 50 Table
Top 50 Insights

February 2020: HCPS DISCUSS GILEAD, EISAI AND MERCK & CO’S TRIAL RESULTS

Top 50 Table
Top 50 Insights

January 2020: NEW YEAR BEGINS WITH FAILED TRIALS AND SUCCESSFUL PODCAST LAUNCH

Top 50 Table
Top 50 Insights

December 2019: @NOVARTIS MOST MENTIONED TWITTER ACCOUNT FOR SECOND MONTH

Top 50 Table
Top 50 Insights

November 2019: GILEAD INTO TOP 5 AFTER PRICE DISCREPANCY

Top 50 Table
Top 50 Insights

October 2019: HCPS ENGAGE WITH TOP 50 PHARMA AROUND GOOD AND BAD NEWS

Top 50 Table
Top 50 Insights

September 2019: HCPS ENGAGED MEANINGFULLY WITH TOP 50 PHARMA

Top 50 Table
Top 50 Insights

August 2019: #WHATHCPSTHINK ABOUT THE TOP 50 PHARMA

Top 50 Table
Top 50 Insights

View all articles >

Meet the Authors

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

CREATION Team photo of Marketing Assistant Chawanzi Chintu

Chawanzi Chintu

As a Marketing assistant,Chawanzi has a passion for creativity and forward-thinking. With a background in media and communications these skills goes hand in hand when it comes to thinking of new and innovative ways to facilitate various marketing processes.

In her free time, Chawanzi balances her time taking care of her cat, pebbles and relaxing with a hydrating face mask.

Suggested next


Top 50 Pharma Tracker: HCPs respond to COVID-19 treatment options

01.07.2020 | Article

Top 50 Pharma Tracker: HCPs respond to COVID-19 treatment options

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

HCPs engage with Top 50 pharma around good and bad news

12.11.2019 | Article

HCPs engage with Top 50 pharma around good and bad news

HCPs engage with Top 50 pharma around good and bad news

By Mary Kangley

View all articles >